» Articles » PMID: 36853809

The Long-range Interaction Between Two GNAS Imprinting Control Regions Delineates Pseudohypoparathyroidism Type 1B Pathogenesis

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2023 Feb 28
PMID 36853809
Authors
Affiliations
Soon will be listed here.
Abstract

Genetic defects of GNAS, the imprinted gene encoding the stimulatory G protein α-subunit, are responsible for multiple diseases. Abnormal GNAS imprinting causes pseudohypoparathyroidism type 1B (PHP1B), a prototype of mammalian end-organ hormone resistance. Hypomethylation at the maternally methylated GNAS A/B region is the only shared defect in patients with PHP1B. In autosomal dominant (AD) PHP1B kindreds, A/B hypomethylation is associated with maternal microdeletions at either the GNAS NESP55 differentially methylated region or the STX16 gene located approximately 170 kb upstream. Functional evidence is meager regarding the causality of these microdeletions. Moreover, the mechanisms linking A/B methylation and the putative imprinting control regions (ICRs) NESP-ICR and STX16-ICR remain unknown. Here, we generated a human embryonic stem cell model of AD-PHP1B by introducing ICR deletions using CRISPR/Cas9. With this model, we showed that the NESP-ICR is required for methylation and transcriptional silencing of A/B on the maternal allele. We also found that the SXT16-ICR is a long-range enhancer of NESP55 transcription, which originates from the maternal NESP-ICR. Furthermore, we demonstrated that the STX16-ICR is an embryonic stage-specific enhancer enabled by the direct binding of pluripotency factors. Our findings uncover an essential GNAS imprinting control mechanism and advance the molecular understanding of PHP1B pathogenesis.

Citing Articles

A biallelically active embryonic enhancer dictates GNAS imprinting through allele-specific conformations.

Iwasaki Y, Reyes M, Juppner H, Bastepe M Nat Commun. 2025; 16(1):1377.

PMID: 39910084 PMC: 11799514. DOI: 10.1038/s41467-025-56608-0.


Recurrent small variants in NESP55/NESPAS associated with broad GNAS methylation defects and pseudohypoparathyroidism type 1B.

Li D, De Beur S, Hou C, Ruzhnikov M, Seeley H, Cutting G JCI Insight. 2024; 9(24).

PMID: 39541438 PMC: 11665564. DOI: 10.1172/jci.insight.185874.


Pseudohypoparathyroidism Type IB with Subclinical Hypothyroidism: a Pedigree Investigation and Literature Review.

Liu J, Lu L, Wei Y, Li Y, Wang Q, Yu L Diabetes Metab Syndr Obes. 2024; 17:2021-2026.

PMID: 38765469 PMC: 11100510. DOI: 10.2147/DMSO.S458405.


Human Reproduction and Disturbed Genomic Imprinting.

Eggermann T Genes (Basel). 2024; 15(2).

PMID: 38397153 PMC: 10888310. DOI: 10.3390/genes15020163.


Editorial: Parathyroid disorders: updates of PTH/serum Ca2+ regulation and therapeutic prospects.

Zhang F, Huang Y, Hu J, Yin S Front Endocrinol (Lausanne). 2024; 14:1354277.

PMID: 38292765 PMC: 10826605. DOI: 10.3389/fendo.2023.1354277.


References
1.
Michienzi S, Cherman N, Holmbeck K, Funari A, Collins M, Bianco P . GNAS transcripts in skeletal progenitors: evidence for random asymmetric allelic expression of Gs alpha. Hum Mol Genet. 2007; 16(16):1921-30. DOI: 10.1093/hmg/ddm139. View

2.
Skene P, Henikoff S . An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites. Elife. 2017; 6. PMC: 5310842. DOI: 10.7554/eLife.21856. View

3.
Elli F, Bordogna P, Arosio M, Spada A, Mantovani G . Mosaicism for GNAS methylation defects associated with pseudohypoparathyroidism type 1B arose in early post-zygotic phases. Clin Epigenetics. 2018; 10:16. PMC: 5801752. DOI: 10.1186/s13148-018-0449-4. View

4.
Keidai Y, Iwasaki Y, Iwasaki K, Honjo S, Bastepe M, Hamasaki A . Sporadic Pseudohypoparathyroidism Type 1B in Monozygotic Twins: Insights Into the Pathogenesis of Methylation Defects. J Clin Endocrinol Metab. 2021; 107(3):e947-e954. PMC: 8851915. DOI: 10.1210/clinem/dgab801. View

5.
Villar D, Berthelot C, Aldridge S, Rayner T, Lukk M, Pignatelli M . Enhancer evolution across 20 mammalian species. Cell. 2015; 160(3):554-66. PMC: 4313353. DOI: 10.1016/j.cell.2015.01.006. View